Published in Laryngoscope on February 01, 2002
Proposal for revision of the European Laryngological Society classification of endoscopic cordectomies. Eur Arch Otorhinolaryngol (2007) 2.30
Treatment of T1b glottic SCC: laser vs. radiation--a Canadian multicenter study. J Otolaryngol Head Neck Surg (2013) 0.91
Laser surgery of T1a glottic carcinomas; significance of resection margins. Eur Arch Otorhinolaryngol (2007) 0.89
Voice quality after endoscopic laser surgery and radiotherapy for early glottic cancer: objective measurements emphasizing the Voice Handicap Index. Eur Arch Otorhinolaryngol (2007) 0.88
Multidisciplinary approach in the treatment of T1 glottic cancer. The role of patient preference in a homogenous patient population. Strahlenther Onkol (2010) 0.87
Oncological outcome after CO2 laser cordectomy for early-stage glottic carcinoma. Acta Otorhinolaryngol Ital (2005) 0.85
Risk of fatal cerebrovascular accidents after external beam radiation therapy for early-stage glottic laryngeal cancer. Head Neck (2013) 0.84
Effect of resection depth of early glottic cancer on vocal outcome: an optimized finite element simulation. Laryngoscope (2015) 0.83
CO₂ laser cordectomy for T1-T2 glottic cancer: oncological and functional long-term results. Eur Arch Otorhinolaryngol (2015) 0.80
Oncological and functional outcome after transoral 532-nm pulsed potassium-titanyl-phosphate laser surgery for T1a glottic carcinoma. Lasers Med Sci (2012) 0.78
Thyroarytenoid muscle invasion in T1 glottic carcinoma. Eur Arch Otorhinolaryngol (2009) 0.75
An empirical study of modified frontolateral partial laryngectomy without tracheotomy. Exp Ther Med (2012) 0.75
Guidelines for the Surgical Management of Laryngeal Cancer: Korean Society of Thyroid-Head and Neck Surgery. Clin Exp Otorhinolaryngol (2017) 0.75
Salvage total laryngectomy after conservation laryngeal surgery for recurrent laryngeal squamous cell carcinoma. Acta Otorhinolaryngol Ital (2016) 0.75
Functional organ preservation in laryngeal and hypopharyngeal cancer. GMS Curr Top Otorhinolaryngol Head Neck Surg (2012) 0.75
CO(2) laser versus cold steel margin analysis following endoscopic excision of glottic cancer. J Otolaryngol Head Neck Surg (2014) 0.75
Risk of lymph node metastases after en bloc cold steel, en bloc laser-, and piecemeal laser surgical resection of auricular VX2 carcinoma. Lasers Med Sci (2012) 0.75
The use of forced ventilation during microlaryngoscopy with laser CO2. Eur Arch Otorhinolaryngol (2008) 0.75
Treatment of Advanced Carcinoma of the Larynx and Hypopharynx with Laser Followed by External Radiotherapy. Iran J Otorhinolaryngol (2017) 0.75
Endolaryngeal cordectomy using cold instruments for treatment of T1 glottic cancers. Eur Arch Otorhinolaryngol (2007) 0.75
Management of surgical margins after endoscopic laser surgery for early glottic cancers: a multicentric evaluation in French-speaking European countries. Eur Arch Otorhinolaryngol (2015) 0.75
High incidence of head and neck squamous cell carcinoma in patients with Fanconi anemia. Arch Otolaryngol Head Neck Surg (2003) 2.56
Prospective functional voice assessment in patients undergoing thyroid surgery. Ann Surg (2002) 2.08
Primary mucosal malignant melanoma of the head and neck. Head Neck (2002) 2.07
Malignancy rate in thyroid nodules classified as Bethesda category III (AUS/FLUS). Thyroid (2014) 2.04
TNM staging of cancers of the head and neck: striving for uniformity among diversity. CA Cancer J Clin (2005) 2.03
Thyroid carcinoma. J Natl Compr Canc Netw (2010) 2.02
Concurrent cetuximab, cisplatin, and concomitant boost radiotherapy for locoregionally advanced, squamous cell head and neck cancer: a pilot phase II study of a new combined-modality paradigm. J Clin Oncol (2006) 1.97
Craniofacial surgery for malignant skull base tumors: report of an international collaborative study. Cancer (2003) 1.94
The mutational landscape of adenoid cystic carcinoma. Nat Genet (2013) 1.83
Correlation of osteoradionecrosis and dental events with dosimetric parameters in intensity-modulated radiation therapy for head-and-neck cancer. Int J Radiat Oncol Biol Phys (2011) 1.80
Poorly differentiated thyroid carcinomas defined on the basis of mitosis and necrosis: a clinicopathologic study of 58 patients. Cancer (2006) 1.79
Intensity-modulated radiotherapy in the treatment of oropharyngeal cancer: an update of the Memorial Sloan-Kettering Cancer Center experience. Int J Radiat Oncol Biol Phys (2010) 1.77
Prognostic indicators of outcomes in patients with distant metastases from differentiated thyroid carcinoma. J Am Coll Surg (2003) 1.74
Management of well-differentiated thyroid carcinoma presenting within a thyroglossal duct cyst. J Surg Oncol (2002) 1.73
Nectin-1 expression by squamous cell carcinoma is a predictor of herpes oncolytic sensitivity. Mol Ther (2007) 1.71
Diagnostic accuracy of 18F-FDG PET in restaging patients with medullary thyroid carcinoma and elevated calcitonin levels. J Nucl Med (2007) 1.69
Clinical utility of 18F-FDG PET/CT in assessing the neck after concurrent chemoradiotherapy for Locoregional advanced head and neck cancer. J Nucl Med (2008) 1.65
Head and neck cancers. J Natl Compr Canc Netw (2011) 1.64
Analysis of prognostic factors in 146 patients with anterior skull base sarcoma: an international collaborative study. Cancer (2007) 1.63
Treatment of anaplastic thyroid carcinoma in vitro with a mutant vaccinia virus. Surgery (2007) 1.54
Head and neck soft tissue sarcomas: a multivariate analysis of outcomes. Ann Surg Oncol (2004) 1.51
Primary mucosal melanoma of the head and neck: a proposal for microstaging localized, Stage I (lymph node-negative) tumors. Cancer (2004) 1.51
18F-FDG PET/CT for detecting nodal metastases in patients with oral cancer staged N0 by clinical examination and CT/MRI. J Nucl Med (2006) 1.46
Double-blind, placebo-controlled, randomized trial of granulocyte-colony stimulating factor during postoperative radiotherapy for squamous head and neck cancer. Cancer J (2006) 1.42
EMLA(®) cream as local anesthetic for radiofrequency turbinate tissue reduction. Eur Arch Otorhinolaryngol (2014) 1.40
A comparison of intensity-modulated radiation therapy and concomitant boost radiotherapy in the setting of concurrent chemotherapy for locally advanced oropharyngeal carcinoma. Int J Radiat Oncol Biol Phys (2006) 1.39
Head and neck cancers, Version 2.2014. Clinical practice guidelines in oncology. J Natl Compr Canc Netw (2014) 1.39
Complications of craniofacial resection for malignant tumors of the skull base: report of an International Collaborative Study. Head Neck (2005) 1.39
FDG-PET detected thyroid incidentalomas: need for further investigation? Ann Surg Oncol (2006) 1.37
Paracrine regulation of pancreatic cancer cell invasion by peripheral nerves. J Natl Cancer Inst (2010) 1.36
Head and neck cancers, version 2.2013. Featured updates to the NCCN guidelines. J Natl Compr Canc Netw (2013) 1.35
Concurrent chemotherapy and intensity-modulated radiotherapy for locoregionally advanced laryngeal and hypopharyngeal cancers. Int J Radiat Oncol Biol Phys (2007) 1.33
Cyclooxygenase-2: a novel molecular target for the prevention and treatment of head and neck cancer. Head Neck (2002) 1.32
Decision making in the management of recurrent head and neck cancer. Head Neck (2013) 1.31
Craniofacial resection for malignant paranasal sinus tumors: Report of an International Collaborative Study. Head Neck (2005) 1.31
Oral tongue cancer gene expression profiling: Identification of novel potential prognosticators by oligonucleotide microarray analysis. BMC Cancer (2009) 1.30
Treatment of nasal cavity and paranasal sinus cancer with modern radiotherapy techniques in the postoperative setting--the MSKCC experience. Int J Radiat Oncol Biol Phys (2006) 1.29
Genome-wide appraisal of thyroid cancer progression. Am J Pathol (2002) 1.28
Clinicopathologic differences in malignant melanoma arising in oral squamous and sinonasal respiratory mucosa of the upper aerodigestive tract. Arch Pathol Lab Med (2003) 1.28
Intensity-modulated radiotherapy in postoperative treatment of oral cavity cancers. Int J Radiat Oncol Biol Phys (2008) 1.27
Oncolytic herpesvirus effectively treats murine squamous cell carcinoma and spreads by natural lymphatics to treat sites of lymphatic metastases. Hum Gene Ther (2002) 1.26
Improved outcomes in patients with osteogenic sarcoma of the head and neck. Cancer (2002) 1.26
Elective and therapeutic selective neck dissection. Oral Oncol (2005) 1.26
Tumor metabolism and perfusion in head and neck squamous cell carcinoma: pretreatment multimodality imaging with 1H magnetic resonance spectroscopy, dynamic contrast-enhanced MRI, and [18F]FDG-PET. Int J Radiat Oncol Biol Phys (2011) 1.26
Malignant minor salivary gland tumors of the larynx. Arch Otolaryngol Head Neck Surg (2006) 1.25
Results of surgical salvage after failure of definitive radiation therapy for early-stage squamous cell carcinoma of the glottic larynx. Arch Otolaryngol Head Neck Surg (2006) 1.25
Re: Extent of surgery affects papillary thyroid cancer. Ann Surg (2008) 1.23
Solitary fibrous tumors of the head and neck: a clinicopathologic and radiologic review. Arch Otolaryngol Head Neck Surg (2006) 1.23
Incidence of inadvertent parathyroid removal during thyroidectomy. Laryngoscope (2002) 1.22
Amplification of the 3q26.3 locus is associated with progression to invasive cancer and is a negative prognostic factor in head and neck squamous cell carcinomas. Am J Pathol (2002) 1.22
Implications for clinical staging of metastatic cutaneous squamous carcinoma of the head and neck based on a multicenter study of treatment outcomes. Cancer (2006) 1.22
Management issues in massive pediatric facial plexiform neurofibroma with neurofibromatosis type 1. Head Neck (2002) 1.20
Lymph node density is a significant predictor of outcome in patients with oral cancer. Cancer (2009) 1.20
The impact of distant metastases at presentation on prognosis in patients with differentiated carcinoma of the thyroid gland. Thyroid (2012) 1.19
Prognostic factors of recurrence in encapsulated Hurthle cell carcinoma of the thyroid gland: a clinicopathologic study of 50 cases. Cancer (2006) 1.19
Intensity-modulated radiation therapy in oropharyngeal carcinoma: effect of tumor volume on clinical outcomes. Int J Radiat Oncol Biol Phys (2011) 1.17
Outcomes and prognostic variables in adenoid cystic carcinoma of the head and neck: a recent experience. Int J Radiat Oncol Biol Phys (2007) 1.16
Genome-wide profiling of papillary thyroid cancer identifies MUC1 as an independent prognostic marker. Cancer Res (2004) 1.16
Unresectable carcinoma of the paranasal sinuses: outcomes and toxicities. Int J Radiat Oncol Biol Phys (2008) 1.15
Neck dissection: then and now. Auris Nasus Larynx (2006) 1.14
The oncologic radicality of supracricoid partial laryngectomy with cricohyoidopexy in the treatment of advanced N0-N1 laryngeal squamous cell carcinoma. Laryngoscope (2012) 1.14
Dynamic contrast-enhanced magnetic resonance imaging as a predictor of outcome in head-and-neck squamous cell carcinoma patients with nodal metastases. Int J Radiat Oncol Biol Phys (2011) 1.14
Thyroid carcinoma. J Natl Compr Canc Netw (2007) 1.13
The role of novel oncogenes squamous cell carcinoma-related oncogene and phosphatidylinositol 3-kinase p110alpha in squamous cell carcinoma of the oral tongue. Clin Cancer Res (2003) 1.11
Angiogenesis inhibition by an oncolytic herpes virus expressing interleukin 12. Clin Cancer Res (2004) 1.08
Hürthle cell carcinoma: a 60-year experience. Ann Surg Oncol (2002) 1.08
The role of operations for distantly metastatic well-differentiated thyroid carcinoma. Surgery (2002) 1.08
Fine-needle aspiration biopsy of salivary gland lesions in a selected patient population. Arch Otolaryngol Head Neck Surg (2004) 1.08
Outcome of craniofacial surgery in children and adolescents with malignant tumors involving the skull base: an international collaborative study. Head Neck (2009) 1.08
The role of pectoralis major muscle flap in salvage total laryngectomy. Arch Otolaryngol Head Neck Surg (2009) 1.07
Encapsulated papillary thyroid carcinoma: a clinico-pathologic study of 106 cases with emphasis on its morphologic subtypes (histologic growth pattern). Thyroid (2009) 1.07
Rosai-Dorfman disease in the larynx. Ear Nose Throat J (2013) 1.07
Prognostic implications of papillary thyroid carcinoma with tall-cell features. Thyroid (2014) 1.06
A new American Joint Committee on Cancer staging system for cutaneous squamous cell carcinoma: creation and rationale for inclusion of tumor (T) characteristics. J Am Acad Dermatol (2011) 1.06
Thyroid lobectomy for treatment of well differentiated intrathyroid malignancy. Surgery (2011) 1.05
Second primary malignancy of the aerodigestive tract in patients treated for cancer of the oral cavity and larynx. Head Neck (2005) 1.05
Thyroid carcinoma. J Natl Compr Canc Netw (2005) 1.04
Proposal for a rational classification of neck dissections. Head Neck (2010) 1.04
Anterior cranial base reconstruction using free tissue transfer: changing trends. Head Neck (2003) 1.04
Factors predicting outcome in malignant minor salivary gland tumors of the oropharynx. Arch Otolaryngol Head Neck Surg (2010) 1.03
Changing trends in well differentiated thyroid carcinoma over eight decades. Int J Surg (2012) 1.03
Craniofacial surgery for esthesioneuroblastoma: report of an international collaborative study. J Neurol Surg B Skull Base (2012) 1.02
Follicular variant of papillary thyroid carcinoma: genome-wide appraisal of a controversial entity. Genes Chromosomes Cancer (2004) 1.02
Histological aggressiveness of fluorodeoxyglucose positron-emission tomogram (FDG-PET)-detected incidental thyroid carcinomas. Ann Surg Oncol (2007) 1.01
Prognostic factors for malignant melanoma of the squamous mucosa of the head and neck. Am J Surg Pathol (2002) 1.01
Head and neck cancers. J Natl Compr Canc Netw (2008) 1.01
Results of selective neck dissection in management of the node-positive neck. Arch Otolaryngol Head Neck Surg (2002) 1.00
Prognostic implication of sentinel lymph node biopsy in cutaneous head and neck melanoma. Head Neck (2010) 1.00
Cancer of the oral cavity: a comparison between institutions in a developing and a developed nation. Head Neck (2004) 1.00
Surgical management of metastases to the thyroid gland. Ann Surg Oncol (2010) 0.99
Rhabdomyoma of the parapharyngeal space presenting with dysphagia. Dysphagia (2007) 0.99
Clinical significance of molecular expression profiles of Hürthle cell tumors of the thyroid gland analyzed via tissue microarrays. Am J Pathol (2002) 0.99
Anterior skull base surgery for malignant tumors: a multivariate analysis of 27 years of experience. Head Neck (2003) 0.99
Supracricoid partial laryngectomy in the treatment of laryngeal cancer: univariate and multivariate analysis of prognostic factors. Arch Otolaryngol Head Neck Surg (2005) 0.99
Anterior and middle cranial fossa skull base reconstruction using microvascular free tissue techniques: surgical complications and functional outcomes. Ann Plast Surg (2008) 0.99
Observation of clinically negative central compartment lymph nodes in papillary thyroid carcinoma. Surgery (2013) 0.98
The impact of microscopic extrathyroid extension on outcome in patients with clinical T1 and T2 well-differentiated thyroid cancer. Surgery (2011) 0.97